Search Results

734 articles with title/keywords/abstract containing Type-2-diabetes-mellitus

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days Antihyperglycaemics: prescribing rate unchanged by rosiglitazone warning

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 4-4(1)

Publisher: Adis International

Content loaded within last 14 days Antihyperglycaemics: prescribing rate unchanged by rosiglitazone warning

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 5-5(1)

Publisher: Adis International

Insulin sensitisers and prompt revascularisation offer little cost benefit

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 592, 2009-11-28 , pp. 1-1(1)

Publisher: Adis International

All-cause death significantly higher with glibenclamide vs gliclazide

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 2-2(1)

Publisher: Adis International

Insulin glargine dually compared

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 12-12(1)

Publisher: Adis International

Diabetes: self monitoring `cost effective' in Bangladesh

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 13-13(1)

Publisher: Adis International

Insulin aspart looks good for T2DM in Japan

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 4-4(1)

Publisher: Adis International

Weekly exenatide demonstrates QOL superiority in T2DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 10-10(1)

Publisher: Adis International

Insulin glargine trumps insulin detemir in Germany

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 6-6(1)

Publisher: Adis International

Uncertainty over cost definitions alters CE results

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 7-7(1)

Publisher: Adis International

The cost efficiency of screening strategies for type 2 diabetes mellitus and glucose intolerance vary considerably

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 9-9(1)

Publisher: Adis International

25-year projections recommended for Washington

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 8-8(1)

Publisher: Adis International

Exenatide trumps insulin glargine in cost effectiveness

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 1-1(1)

Publisher: Adis International

Depression, SLE and diabetes drug markets set for growth

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 10-10(1)

Publisher: Adis International

Microvascular complications double diabetes cost

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 7-7(1)

Publisher: Adis International

Treatment of diabetes suboptimal in US

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 8-8(1)

Publisher: Adis International

Pioglitazone: better cardiac safety profile than rosiglitazone

Source: Reactions, Volume 1, Number 1267, 2009-08-29 , pp. 4-4(1)

Publisher: Adis International

Vascular complications predict resource use in T2DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 7-7(1)

Publisher: Adis International

Metformin/pioglitazone a dominant diabetes strategy

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 7-7(1)

Publisher: Adis International

Colesevelam provides economic benefit in T2DM treatment

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 582, 2009-07-11 , pp. 4-4(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A